West Pharmaceutical Services to Participate in Notable Investor Conferences
West Pharmaceutical Services, Inc. (NYSE: WST), known for its leadership in providing innovative solutions for injectable drug administration, is gearing up for a series of investor conferences that will showcase its advancements and business strategy. Here’s a detailed overview of what to expect from these important events.
Conference Schedule
West Pharmaceutical has announced participation in the following investor conferences:
1.
UBS Global Healthcare Conference
Date: Tuesday, November 11, 2025
Time: 9:30 AM ET
Location: Palm Beach Gardens, FL
This conference will feature a fireside chat where key executives from West will discuss recent innovations and market trends affecting the pharmaceutical landscape.
2.
Jefferies Global Healthcare Conference
Date: Tuesday, November 18, 2025
Time: 10:00 AM GMT
Location: London, UK
The discussion will focus on West's global reach and its commitment to improving drug delivery solutions for healthcare providers.
3.
Stephens Annual Investment Conference
Date: Thursday, November 20, 2025
Time: 11:00 AM CT
Location: Nashville, TN
Investors will gain insights into West's operational strategies and financial performance during this interactive session.
4.
Citi Global Healthcare Conference
Date: Tuesday, December 2, 2025
Time: 2:30 PM ET
Location: Miami, FL
This conference will provide a prime opportunity to hear about West's latest projects and future initiatives aimed at enhancing patient safety and drug efficacy.
Accessing the Presentations
For those unable to attend in person, West will offer live webcasts for each session, which can be accessed through the Investors section of their official website. Additionally, replays of these webcasts will be available on the site for approximately 90 days after each event, allowing investors and stakeholders to stay updated on the latest developments and discussions.
About West Pharmaceutical Services
West Pharmaceutical Services stands out as a leading manufacturer and supplier of high-quality injectable solutions and services. Their products play a crucial role in the healthcare sector, ensuring the safe and effective containment and delivery of essential medicines.
With a workforce exceeding 10,000 employees stationed in 50 locations, including 25 manufacturing facilities worldwide, West handles the delivery of over 41 billion components and devices each year. The company's solid performance is underscored by a reported revenue of $2.89 billion in fiscal year 2024, a testament to their market presence and operational efficiency.
Headquartered in Exton, Pennsylvania, West Pharmaceutical is listed on the New York Stock Exchange as WST, and it is proud to be part of the S&P 500 index, reflecting its prominent position in the industry. As they prepare for the upcoming conferences, West emphasizes its commitment to enhancing the healthcare sector through innovative solutions.
For more information about West Pharmaceutical Services and updates regarding the conferences, visit their official website at
www.westpharma.com.
Stay tuned for their insights and strategic discussions at these pivotal events.